venBio Partners LLC

Holdings History for ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Symbol: ALXO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	5.1%	0%	$10,960,915	9,699,925	0		$1.13	Q4 2025
30 Sep 2025	10%	0%	$17,750,863	9,699,925	0		$1.83	Q3 2025
30 Jun 2025	3.5%	0%	$4,026,439	9,699,925	0		$0.42	Q2 2025
31 Mar 2025	4.9%	0%	$6,043,053	9,699,925	0		$0.62	Q1 2025
31 Dec 2024	9.5%	0%	$16,198,875	9,699,925	0		$1.67	Q4 2024
30 Sep 2024	9.1%	0%	$17,653,864	9,699,925	0		$1.82	Q3 2024
30 Jun 2024	25%	0%	$58,490,548	9,699,925	0		$6.03	Q2 2024
31 Mar 2024	38%	0%	$108,154,164	9,699,925	0		$11.15	Q1 2024
31 Dec 2023	22%	0%	$144,431,883	9,699,925	0		$14.89	Q4 2023
30 Sep 2023	13%	0%	$46,559,640	9,699,925	0		$4.80	Q3 2023
30 Jun 2023	26%	0%	$72,846,437	9,699,925	0		$7.51	Q2 2023
31 Mar 2023	24%	0%	$43,843,661	9,699,925	0		$4.52	Q1 2023
31 Dec 2022	34%	0%	$109,318,155	9,699,925	0		$11.27	Q4 2022
30 Sep 2022	21%	0%	$92,828,000	9,699,925	0		$9.57	Q3 2022
30 Jun 2022	22%	0%	$78,472,000	9,699,925	0		$8.09	Q2 2022
31 Mar 2022	36%	0%	$163,929,000	9,699,925	0		$16.90	Q1 2022
31 Dec 2021	38%	0%	$208,451,000	9,699,925	0		$21.49	Q4 2021
30 Sep 2021	71%	0%	$716,436,000	9,699,925	0		$73.86	Q3 2021
30 Jun 2021	63%	0%	$530,392,000	9,699,925	0		$54.68	Q2 2021
31 Mar 2021	68%	0%	$715,272,000	9,699,925	0		$73.74	Q1 2021
31 Dec 2020	74%	0%	$836,134,000	9,699,925	0		$86.20	Q4 2020
30 Sep 2020	56%	+56%	$366,075,000	9,699,925	+9,699,925	NEW	$37.74	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.